Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: @milestone

@milestone

posted on Aug 07, 2008 12:20PM

"In the event of a RS, while the number of shares held will fall by the RS ratio eg 10,000,000 on a 1-for10 basis would reduce the number to 1,000,000, the actual percentage holding would remain the same ie 10% pre RS would still be 10% post RS."

Hi milestone,

though of course I know, how a RS works, and though it was NOT my question, I thank you for your objective answer.

But I'll ask my question somewhere else, as it seems it is too specific or too difficult or I'm too dumb to write it understandable.

Take care until the 10k!



Share
New Message
Please login to post a reply